Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT03373084 Recruiting - Sport Injury Clinical Trials

Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism.

HAMMER
Start date: February 14, 2018
Phase:
Study type: Observational

Hamstring muscle injuries are a common pathology in sports mainly present in sprint and acceleration sports, accounting for about 12% of all football injuries. Because of their frequency, risk of reinjury and financial cost, they can be considered as a public health problem. Improving knowledge of the pathophysiology of hamstring muscle injury appears to be a relevant research focus for prevention purposes.

NCT ID: NCT03368092 Recruiting - Clinical trials for Respiratory Distress Syndrome, Adult

Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma

TRAUMADORNASE
Start date: March 4, 2019
Phase: Phase 3
Study type: Interventional

Severe hypoxemia following trauma may happen in many circumstances (aspiration, ventilation-associated pneumonia, lung contusion...), most of which are not exclusively associated with a direct injury to the lungs. Severe trauma and associated musculoskeletal injuries result in the acute release of Damage-Associated Molecular Patterns (DAMPs) in plasma, many of which are made of nucleic acids. DAMPs then bind leukocytes and trigger NETosis (Neutrophil Extracellular Traps), the release of nuclear material coated with proteolytic enzymes, which ultimately promotes remote lung injury and acute respiratory distress syndrome (ARDS). Considering that many DAMPs and all NETs are made of nucleic acids, we hypothesize that dornase alfa, a commercially available recombinant desoxyribonuclease (DNAse) could reduce DAMPs and NETs-induced lung injury in severe trauma patients under mechanical ventilation in the intensive care unit (ICU). The primary objective is to demonstrate a reduction in the incidence of moderate to severe ARDS in severe trauma patients during the first seven ICU days from 45% to 30% by providing aerosolized dornase alfa once during the first two consecutive ICU days and compared to equivalent provision of placebo (NaCl 0,9%). The secondary objectives are to demonstrate, by using aerosolized dornase alfa compared to placebo: - an improvement in static lung compliance - a reduction in mechanical ventilation duration / an increase in ventilation-free ICU days - a reduction in the length of ICU stay - a reduction in the hospital length of stay - a reduction in multi-organ failure - a reduction in ventilator-associated pneumonia (VAP) - a reduction in mortality at day 28

NCT ID: NCT03357835 Recruiting - Trauma Clinical Trials

Trauma Triage Decision With Software (TraumaDS)

TraumaDS
Start date: November 1, 2017
Phase: N/A
Study type: Observational

It is intended to show that a computer software called Trauma Decision System (TravmaDS) for the determination of the urgency of trauma patients who applied to Emergency Medical Clinic gives more accurate, more objective, faster results than the triage scored by medical and non-medical personnel and to show the fact that TraumaDS provides more patient satisfaction.

NCT ID: NCT03340792 Recruiting - Clinical trials for Spinal Cord Injuries

Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury

Start date: November 23, 2017
Phase: N/A
Study type: Interventional

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life. Ten patients with paraplegia caused by spinal cord injury will be recruited from the out-patient clinic of Department of Physical Medicine and Rehabilitation at the China Medical University hospital. All participants will undergo dual X-ray absorptiometry to evaluate the baseline bone mineral density. Eligible participants will then take ReWalk training sessions comprises of 3 x 1-hour sessions per week for 40 sessions. A comprehensive battery of outcome measures, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life, will be utilized for comparison after 40 sessions of ReWalk ambulation training.

NCT ID: NCT03321370 Recruiting - Clinical trials for Traumatic Brain Injury

Cortical Spreading Depolarization After Severe Traumatic Brain Injury

Start date: August 14, 2019
Phase:
Study type: Observational

Preliminary evaluation of electrodes placed on the brain for recording brain activity and novel algorithms to determine cortical spreading depolarization foci of origination following severe traumatic brain injury requiring neurosurgical intervention.

NCT ID: NCT03320759 Recruiting - Clinical trials for Spinal Cord Injuries

Enhancing Recovery in Non-Traumatic Spinal Cord Injury

Start date: August 21, 2018
Phase: N/A
Study type: Interventional

The investigators have spent the last decade uncovering unique metabolic and functional abnormalities in the brains of patients with spinal cord compression. Degenerative spinal cord compression represents a unique model of reversible spinal cord injury. In the investigator's previous work, they have demonstrated that cortical reorganization and recruitment is associated with metabolic changes in the brains of patients recovering from spinal cord compression and is correlated with recovery and improved neurological scores. The goal of this study is to combine a rigorous platform of clinical care that includes preoperative evaluation, surgery, and rehabilitation, with state of the art imaging techniques to demonstrate how rehabilitative therapy can increase brain plasticity and recovery of neurological function in patients with spinal cord injury. Neurological function will be carefully evaluated in two groups of patients, those receiving rehabilitation and those not receiving rehabilitation after spine surgery, and will be correlated with the results of advanced imaging.

NCT ID: NCT03319017 Recruiting - Trauma Clinical Trials

Apoptosis in Polymorphonuclear Cells and Inflammatory Cytokines of Trauma Patients

Start date: December 1, 2017
Phase: N/A
Study type: Observational

This study tries to find how hypoxia and hyperoxia, among types of the respiratory failure induced cell damage that can arise in the course of traumatic damage and treatment, influences apoptosis of PMN cells and IL-6 and tumor necrosis factor(TNF)-α as inflammatory cytokines.

NCT ID: NCT03314350 Recruiting - Malnutrition Clinical Trials

Prevalence of Wound Healing Disturbances in Geriatric Inpatients (WONDER Study)

Start date: November 1, 2017
Phase:
Study type: Observational

In geriatric patients, there is a plethora of nutritional and illness-related parameters, resulting in a complex situation which hampers identification of risk factors.In the planned prospective study, the point and period prevalence of wound healing disorders (WHD) is examined at admission and at discharge in a cohort of 517 male and female geriatric patients. As the investigators are also interested to study the occurrence of WHD in patients with malnutrition (and other geriatric phenomena) compared to the prevalence of WHD in patients with a good nutritional Status.

NCT ID: NCT03309930 Recruiting - Clinical trials for Traumatic Brain Injury

Narrative Comprehension by People With Acquired Brain Injury

Start date: October 6, 2017
Phase: N/A
Study type: Interventional

The purpose of this two phase study is to evaluate comprehension by people with acquired brain injury. The phase 1 portion of the study will examine comprehension of narrative paragraphs under 3 conditions: (a) written text only, (b) auditory output only (i.e., synthetic speech - David voice) or combined written text and auditory output. The phase 2 portion of the study is to evaluate comprehension of sentences and paragraphs produced with computer generated (synthesized) speech and digitized natural speech after multiple exposures.

NCT ID: NCT03304899 Recruiting - Clinical trials for Traumatic Brain Injury

Fibrinogen Concentrate in Isolated Traumatic Brain Injury

Start date: October 23, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Fibrinogen is a unique precursor of fibrin and cannot be compensated for by other coagulation factors. If plasma fibrinogen concentrations are insufficient, hemostatic clots cannot be formed with the appropriate firmness. In severe traumatic brain injury(TBI) patients, plasma fibrinogen concentrations decrease earlier and more frequently than other coagulation factors,predicting massive bleeding and death. The purpose of this study is to try early injection of fibrinogen concentrate in severe isolated traumatic brain injury and investigation the effect of it on post bleeding and complications.